HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 83 filers reported holding HARVARD BIOSCIENCE INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47 | -21.7% | 11,000 | 0.0% | 0.00% | – |
| Q2 2023 | $60 | +30.4% | 11,000 | 0.0% | 0.00% | – |
| Q1 2023 | $46 | -2.1% | 11,000 | -35.3% | 0.00% | – |
| Q4 2022 | $47 | -99.9% | 17,000 | 0.0% | 0.00% | – |
| Q3 2022 | $44,000 | -29.0% | 17,000 | 0.0% | 0.00% | – |
| Q2 2022 | $62,000 | -41.5% | 17,000 | 0.0% | 0.00% | – |
| Q1 2022 | $106,000 | -11.7% | 17,000 | 0.0% | 0.00% | – |
| Q4 2021 | $120,000 | +0.8% | 17,000 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $119,000 | -16.2% | 17,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $142,000 | +52.7% | 17,000 | 0.0% | 0.00% | – |
| Q1 2021 | $93,000 | +27.4% | 17,000 | 0.0% | 0.00% | – |
| Q4 2020 | $73,000 | +43.1% | 17,000 | 0.0% | 0.00% | – |
| Q3 2020 | $51,000 | -3.8% | 17,000 | 0.0% | 0.00% | – |
| Q2 2020 | $53,000 | -13.1% | 17,000 | +61.1% | 0.00% | -100.0% |
| Q1 2015 | $61,000 | – | 10,550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Harvey Partners, LLC | 1,020,036 | $7,120,000 | 5.32% |
| Portolan Capital Management | 2,358,010 | $16,459,000 | 1.20% |
| Acuitas Investments, LLC | 375,836 | $2,623,000 | 1.14% |
| Parkman Healthcare Partners LLC | 475,367 | $3,318,000 | 0.84% |
| Adirondack Research & Management Inc. | 90,020 | $628,000 | 0.76% |
| Archon Capital Management LLC | 736,236 | $5,139,000 | 0.73% |
| BARD ASSOCIATES INC | 294,697 | $2,057,000 | 0.70% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,621,775 | $11,320,000 | 0.65% |
| GLOBEFLEX CAPITAL L P | 268,466 | $1,874,000 | 0.41% |
| Monarch Partners Asset Management LLC | 330,083 | $2,304,000 | 0.34% |